Published in Endocrinology on January 25, 2011
Stimulation of host bone marrow stromal cells by sympathetic nerves promotes breast cancer bone metastasis in mice. PLoS Biol (2012) 2.58
Marrow fat metabolism is linked to the systemic energy metabolism. Bone (2011) 1.23
Biomolecular basis of the role of diabetes mellitus in osteoporosis and bone fractures. World J Diabetes (2013) 0.86
Control of bone remodeling by the peripheral sympathetic nervous system. Calcif Tissue Int (2013) 0.85
β-Adrenergic receptor antagonists and fracture risk: a meta-analysis of selectivity, gender, and site-specific effects. Osteoporos Int (2013) 0.84
Bone health and associated metabolic complications in neuromuscular diseases. Phys Med Rehabil Clin N Am (2012) 0.80
Lasting consequences of traumatic events on behavioral and skeletal parameters in a mouse model for post-traumatic stress disorder (PTSD). PLoS One (2012) 0.78
Skeletal integration of energy homeostasis: Translational implications. Bone (2015) 0.76
Bone mineral density in spinal cord injury: an evaluation of the distal femur. J Osteoporos (2012) 0.76
Force-induced Adrb2 in periodontal ligament cells promotes tooth movement. J Dent Res (2014) 0.76
Osteogenic potential of osteoblasts from neonatal rats born to mothers treated with caffeine throughout pregnancy. BMC Musculoskelet Disord (2015) 0.75
Chronic stress, sympathetic activation and skeletal metastasis of breast cancer cells. Bonekey Rep (2015) 0.75
Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell (2006) 7.23
Steroid hormone receptors: many actors in search of a plot. Cell (1995) 7.22
Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature (2005) 6.43
Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev (2000) 6.42
Leptin regulates bone formation via the sympathetic nervous system. Cell (2002) 5.95
Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest (1998) 5.03
The molecular clock mediates leptin-regulated bone formation. Cell (2005) 3.88
Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med (1990) 3.29
Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J Clin Invest (2000) 3.15
Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology (1999) 2.69
Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocr Rev (1993) 2.05
Glucocorticoids suppress bone formation via the osteoclast. J Clin Invest (2006) 1.92
Glucocorticoid induction of the rat tryptophan oxygenase gene is mediated by two widely separated glucocorticoid-responsive elements. EMBO J (1987) 1.87
New twists in gene regulation by glucocorticoid receptor: is DNA binding dispensable? Cell (1998) 1.84
Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. Cell Metab (2010) 1.79
Quantifying osteoblast and osteocyte apoptosis: challenges and rewards. J Bone Miner Res (2007) 1.66
Structure of the gene for human beta 2-adrenergic receptor: expression and promoter characterization. Proc Natl Acad Sci U S A (1987) 1.62
Use of beta-blockers and risk of fractures. JAMA (2004) 1.58
Beta-adrenergic blockers reduce the risk of fracture partly by increasing bone mineral density: Geelong Osteoporosis Study. J Bone Miner Res (2004) 1.50
Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study. J Hypertens (2006) 1.48
Clinical review 83: Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab (1996) 1.41
Protective effects of a glucocorticoid on downregulation of pulmonary beta 2-adrenergic receptors in vivo. J Clin Invest (1995) 1.41
Mechanisms of glucocorticoid action in bone. Ann N Y Acad Sci (2002) 1.39
Glucocorticoid suppresses the canonical Wnt signal in cultured human osteoblasts. Biochem Biophys Res Commun (2005) 1.37
Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: a longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice. Arthritis Rheum (2008) 1.36
Beta-adrenergic receptors in hamster smooth muscle cells are transcriptionally regulated by glucocorticoids. J Biol Chem (1988) 1.35
Glucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralization. Arthritis Rheum (2008) 1.33
Thyroid-adrenergic interactions: physiological and clinical implications. Thyroid (2008) 1.30
Transcription of the genes for 5S ribosomal RNA and transfer RNA in isolated mouse myeloma cell nuclei. Biochemistry (1974) 1.30
Agonist-induced destabilization of beta-adrenergic receptor mRNA. Attenuation of glucocorticoid-induced up-regulation of beta-adrenergic receptors. J Biol Chem (1989) 1.26
Effects of cortisol and bone morphogenetic protein-2 on stromal cell differentiation: correlation with CCAAT-enhancer binding protein expression. Bone (2002) 1.22
Glucocorticoid osteoporosis--mechanisms and management. Eur J Endocrinol (1997) 1.21
Effects of antihypertensive drug treatments on fracture outcomes: a meta-analysis of observational studies. J Intern Med (2006) 1.20
High concentrations of dexamethasone suppress the proliferation but not the differentiation or further maturation of human osteoblast precursors in vitro: relevance to glucocorticoid-induced osteoporosis. Rheumatology (Oxford) (2001) 1.19
Post-transcriptional and nongenomic effects of glucocorticoids. Proc Am Thorac Soc (2004) 1.17
Transcription of RNA in isolated nuclei. Methods Cell Biol (1978) 1.13
Blockade of beta-adrenergic signaling does not influence the bone mechano-adaptive response in mice. Bone (2007) 1.10
Glucocorticoids increase pulmonary beta-adrenergic receptors in fetal rabbit. Endocrinology (1980) 1.06
Effects of low-dose prednisone on bone metabolism. J Bone Miner Res (2004) 1.05
Secreted frizzled-related protein 1 modulates glucocorticoid attenuation of osteogenic activities and bone mass. Endocrinology (2005) 1.04
Low dose beta-blocker prevents ovariectomy-induced bone loss in rats without affecting heart functions. J Cell Physiol (2008) 1.04
Inhibition of mitogen-activated protein kinase activity and proliferation of an early osteoblast cell line (MBA 15.4) by dexamethasone: role of protein phosphatases. Endocrinology (1998) 1.03
Use of beta-blockers and the risk of hip/femur fracture in the United Kingdom and The Netherlands. Calcif Tissue Int (2007) 1.01
Effects of a beta-blocker on bone turnover in normal postmenopausal women: a randomized controlled trial. J Clin Endocrinol Metab (2005) 0.99
Differential regulation of beta 1- and beta 2-adrenergic receptor protein and mRNA levels by glucocorticoids during 3T3-F442A adipose differentiation. J Biol Chem (1990) 0.99
Effects of propranolol on bone metabolism in spontaneously hypertensive rats. J Pharmacol Exp Ther (2010) 0.98
Dose effects of propranolol on cancellous and cortical bone in ovariectomized adult rats. J Pharmacol Exp Ther (2006) 0.98
Beta-blocker use and risk of fractures in men and women from the general population: the MONICA/KORA Augsburg cohort study. Osteoporos Int (2007) 0.98
Fracture risk in perimenopausal women treated with beta-blockers. Calcif Tissue Int (2004) 0.96
Beta-blockers increase bone mineral density. Clin Orthop Relat Res (2006) 0.96
Glucocorticoid-induced osteoporosis: both in vivo and in vitro concentrations of glucocorticoids higher than physiological levels attenuate osteoblast differentiation. J Bone Miner Res (1998) 0.96
Influence of glucocorticoids on human osteoclast generation and activity. J Bone Miner Res (2004) 0.96
Molecular mechanisms of corticosteroid actions. Monaldi Arch Chest Dis (2000) 0.93
Glucocorticoid-induced bone fragility. Ann N Y Acad Sci (2010) 0.92
Cortisol downregulates osteoblast alpha 1 (I) procollagen mRNA by transcriptional and posttranscriptional mechanisms. J Cell Biochem (1995) 0.91
Regulation of bim in glucocorticoid-mediated osteoblast apoptosis. J Cell Physiol (2008) 0.91
Use of beta-2 agonists and risk of hip/femur fracture: a population-based case-control study. Pharmacoepidemiol Drug Saf (2007) 0.90
Evidence that glucocorticoid response elements in the 5'-noncoding region of the hamster beta 2-adrenergic receptor gene are obligate for glucocorticoid regulation of receptor mRNA levels. Biochem Biophys Res Commun (1988) 0.90
Effect of glucocorticoids on bone density. Med Pediatr Oncol (2003) 0.89
Identification of a glucocorticoid response element in the rat beta2-adrenergic receptor gene. Mol Pharmacol (1998) 0.88
Nuclear run-on assay. Cold Spring Harb Protoc (2009) 0.88
Sensitivity of bone to glucocorticoids. Clin Sci (Lond) (2004) 0.87
Dexamethasone effects on beta-adrenergic receptors and adenylate cyclase regulatory proteins Gs and Gi in ROS 17/2.8 cells. Endocrinology (1986) 0.86
Combined effects of exercise and propranolol on bone tissue in ovariectomized rats. J Bone Miner Res (2007) 0.86
Nuclear factor-kappa B augments beta(2)-adrenergic receptor expression in human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol (2001) 0.85
Regulation of beta-adrenoceptor density and mRNA levels in the rat heart cell-line H9c2. Biochem J (1996) 0.83
Genetic regulation of beta 2-adrenergic receptors in 3T3-L1 fibroblasts. Biochem J (1989) 0.83
Glucocorticoid regulation of osteoclast differentiation and expression of receptor activator of nuclear factor-kappaB (NF-kappaB) ligand, osteoprotegerin, and receptor activator of NF-kappaB in mouse calvarial bones. Endocrinology (2006) 0.83
IL-1beta enhances beta2-adrenergic receptor expression in human airway epithelial cells by activating PKC. Am J Physiol Lung Cell Mol Physiol (2001) 0.83
Glucocorticoid induction of beta-adrenergic receptors in the DDT1 MF-2 smooth muscle cell line involves synthesis of new receptor. Mol Cell Biochem (1987) 0.82
Relationship between osteoporosis and arthritis and effect of corticosteroids and other drugs on bone. Curr Opin Rheumatol (1996) 0.82
Close reciprocal regulation of beta 1- and beta 2-adrenergic receptors by dexamethasone in C6 glioma cells: effects on catecholamine responsiveness. Mol Pharmacol (1993) 0.81
Doping dose of salbutamol and exercise training: impact on the skeleton of ovariectomized rats. J Appl Physiol (1985) (2007) 0.80
Regulation of beta 2-adrenergic receptors in keratinocytes: glucocorticoids increase steady-state levels of receptor mRNA in foetal rat keratinizing epidermal cells (FRSK cells). Br J Dermatol (1991) 0.80
Nuclear "run-on" transcription assays. Methods Mol Biol (1995) 0.78
Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature (2005) 6.43
Leptin regulates bone formation via the sympathetic nervous system. Cell (2002) 5.95
Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell (2004) 5.80
A twist code determines the onset of osteoblast differentiation. Dev Cell (2004) 5.40
Stimulation of host bone marrow stromal cells by sympathetic nerves promotes breast cancer bone metastasis in mice. PLoS Biol (2012) 2.58
Cooperative interactions between activating transcription factor 4 and Runx2/Cbfa1 stimulate osteoblast-specific osteocalcin gene expression. J Biol Chem (2005) 1.91
Characterization of 1H NMR signal in human cortical bone for magnetic resonance imaging. Magn Reson Med (2010) 1.82
Essential role of STAT3 in body weight and glucose homeostasis. Mol Cell Biol (2004) 1.74
Transcriptional coactivation of bone-specific transcription factor Cbfa1 by TAZ. Mol Cell Biol (2003) 1.69
Silent information regulator (Sir)T1 inhibits NF-κB signaling to maintain normal skeletal remodeling. J Bone Miner Res (2013) 1.54
CD36-facilitated fatty acid uptake inhibits leptin production and signaling in adipose tissue. Diabetes (2007) 1.41
Clinically compatible MRI strategies for discriminating bound and pore water in cortical bone. Magn Reson Med (2012) 1.38
Enhanced bone formation in lipodystrophic PPARgamma(hyp/hyp) mice relocates haematopoiesis to the spleen. EMBO Rep (2004) 1.37
Non-invasive predictors of human cortical bone mechanical properties: T(2)-discriminated H NMR compared with high resolution X-ray. PLoS One (2011) 1.37
The use of nanoindentation for characterizing the properties of mineralized hard tissues: state-of-the art review. J Biomed Mater Res B Appl Biomater (2008) 1.27
Osteoclasts in multiple myeloma are derived from Gr-1+CD11b+myeloid-derived suppressor cells. PLoS One (2012) 1.25
Inhibition of TGF-β signaling by 1D11 antibody treatment increases bone mass and quality in vivo. J Bone Miner Res (2010) 1.15
Boning up on ephrin signaling. Cell (2006) 1.15
Atf4 regulates chondrocyte proliferation and differentiation during endochondral ossification by activating Ihh transcription. Development (2009) 1.15
Type 1 diabetes in young rats leads to progressive trabecular bone loss, cessation of cortical bone growth, and diminished whole bone strength and fatigue life. J Bone Miner Res (2009) 1.14
Validation of quantitative bound- and pore-water imaging in cortical bone. Magn Reson Med (2013) 1.12
Genetic mouse models for bone studies--strengths and limitations. Bone (2011) 1.10
Transforming growth factor β suppresses osteoblast differentiation via the vimentin activating transcription factor 4 (ATF4) axis. J Biol Chem (2012) 1.10
Anti-transforming growth factor ß antibody treatment rescues bone loss and prevents breast cancer metastasis to bone. PLoS One (2011) 1.08
Models of bone metastasis. J Vis Exp (2012) 1.08
Mice lacking Nf1 in osteochondroprogenitor cells display skeletal dysplasia similar to patients with neurofibromatosis type I. Hum Mol Genet (2011) 1.06
Micro-computed tomography assessment of the progression of fracture healing in mice. Bone (2012) 1.06
The effects of rhBMP-2 released from biodegradable polyurethane/microsphere composite scaffolds on new bone formation in rat femora. Biomaterials (2009) 1.05
Vimentin inhibits ATF4-mediated osteocalcin transcription and osteoblast differentiation. J Biol Chem (2009) 1.02
A novel approach to assess post-yield energy dissipation of bone in tension. J Biomech (2007) 0.99
Raman and mechanical properties correlate at whole bone- and tissue-levels in a genetic mouse model. J Biomech (2010) 0.98
Reversible skeletal abnormalities in gamma-glutamyl transpeptidase-deficient mice. Endocrinology (2003) 0.95
Regulation of adiponectin production by insulin: interactions with tumor necrosis factor-α and interleukin-6. Am J Physiol Endocrinol Metab (2010) 0.94
Polarization control of Raman spectroscopy optimizes the assessment of bone tissue. J Biomed Opt (2013) 0.94
Macrophage Mal1 deficiency suppresses atherosclerosis in low-density lipoprotein receptor-null mice by activating peroxisome proliferator-activated receptor-γ-regulated genes. Arterioscler Thromb Vasc Biol (2011) 0.93
Cocaine and amphetamine-regulated transcript may regulate bone remodeling as a circulating molecule. Endocrinology (2008) 0.92
Chondrocytic Atf4 regulates osteoblast differentiation and function via Ihh. Development (2011) 0.92
Bmp2 in osteoblasts of periosteum and trabecular bone links bone formation to vascularization and mesenchymal stem cells. J Cell Sci (2013) 0.92
Common endocrine control of body weight, reproduction, and bone mass. Annu Rev Nutr (2003) 0.92
Fibrinolysis is essential for fracture repair and prevention of heterotopic ossification. J Clin Invest (2015) 0.91
Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts. J Bone Miner Res (2010) 0.88
Bone remodeling is regulated by inner ear vestibular signals. J Bone Miner Res (2013) 0.88
Synthesis, characterization, and remodeling of weight-bearing allograft bone/polyurethane composites in the rabbit. Acta Biomater (2010) 0.87
Integrated system for combined Raman spectroscopy-spectral domain optical coherence tomography. J Biomed Opt (2011) 0.87
Approaches to treating NF1 tibial pseudarthrosis: consensus from the Children's Tumor Foundation NF1 Bone Abnormalities Consortium. J Pediatr Orthop (2013) 0.86
Hedgehog coordination of postnatal osteoclast and osteoblast activities. Dev Cell (2008) 0.85
Transdermal lovastatin enhances fracture repair in rats. J Bone Miner Res (2008) 0.85
The ras-GTPase activity of neurofibromin restrains ERK-dependent FGFR signaling during endochondral bone formation. Hum Mol Genet (2013) 0.84
The Role of Water Compartments in the Material Properties of Cortical Bone. Calcif Tissue Int (2015) 0.84
Osteo-promoting effects of insulin-like growth factor I (IGF-I) in a mouse model of type 1 diabetes. Bone (2013) 0.83
Extracellular norepinephrine clearance by the norepinephrine transporter is required for skeletal homeostasis. J Biol Chem (2013) 0.83
Comment on "Phonemic diversity supports a serial founder effect model of language expansion from Africa". Science (2012) 0.83
Genome-wide identification of heat shock proteins (Hsps) and Hsp interactors in rice: Hsp70s as a case study. BMC Genomics (2014) 0.82
Very low density lipoprotein receptor (VLDLR) expression is a determinant factor in adipose tissue inflammation and adipocyte-macrophage interaction. J Biol Chem (2013) 0.82
Fibrin accumulation secondary to loss of plasmin-mediated fibrinolysis drives inflammatory osteoporosis in mice. Arthritis Rheumatol (2014) 0.82
Biomechanical evaluation of physeal-sparing fixation methods in tibial eminence fractures. Am J Sports Med (2013) 0.81
Fracture healing in protease-activated receptor-2 deficient mice. J Orthop Res (2012) 0.81
Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice. J Bone Miner Res (2015) 0.80
Effect and mechanism of persulfate activated by different methods for PAHs removal in soil. J Hazard Mater (2013) 0.80
Differential development of the distal and proximal femoral epiphysis and physis in mice. Bone (2012) 0.80
Synergistic effect of exercise and statins on femoral strength in rats. Exp Gerontol (2013) 0.78
Macrophage Apoptosis and Efferocytosis in the Pathogenesis of Atherosclerosis. Circ J (2016) 0.77
Corrigendum: Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1. Nat Med (2015) 0.77
Fibrinolysis is essential for fracture repair and prevention of heterotopic ossification. J Clin Invest (2015) 0.76
Prediction and identification of the effectors of heterotrimeric G proteins in rice (Oryza sativa L.). Brief Bioinform (2017) 0.76
In Vivo Quantitative MR Imaging of Bound and Pore Water in Cortical Bone. Radiology (2015) 0.75
Metronidazole amino acidum natrium combined with radiation in the treatment of nasopharyngeal carcinoma: A meta-analysis based on randomized controlled trials. J Cancer Res Ther (2015) 0.75
[Discussion on several key points of decision support system for remediation of contaminated sites]. Huan Jing Ke Xue (2014) 0.75
[Control of body mass by leptin occurs through the sympathetic nervous system]. Med Sci (Paris) (2003) 0.75
A sustained release of lovastatin from biodegradable, elastomeric polyurethane scaffolds for enhanced bone regeneration. Tissue Eng Part A (2010) 0.75
Manipulation of wavefront using helical metamaterials. Opt Express (2016) 0.75
[Plasma estrogen level and estrogen receptors expression in palatine tonsils in male patients with obstructive sleep apnea hypopnea syndrome]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (2014) 0.75
Prediction of protein-protein interactions between fungus (Magnaporthe grisea) and rice (Oryza sativa L.). Brief Bioinform (2017) 0.75